![]() Bolt Biotherapeutics Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer. | Forbius Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases. | TC BioPharm TC Biopharm (Holdings) is a clinical-stage cell therapy company developing immunotherapy products. | ![]() NextCure NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs. | ![]() Immunicom Immunicom is a company that develops and commercializes a non-drug-based cancer therapy in order to reduce treatment side effects and enhance its response rates. | |
Founding Date | Founding Date 2015 | Founding Date 2011 | Founding Date 2013 | Founding Date 2015 | Founding Date 2013 |
Type | Type Public | Type Subsidiary | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Redwood City, US HQ | Locations Austin, US HQ Montréal, CA | Locations Holytown, GB HQ Leiden, NL Edinburgh, GB London, GB | Locations Beltsville, US HQ | Locations San Diego, US HQ |
Employees | Employees 943% increase | Employees 913% increase | Employees 41 | Employees N/A | Employees 25 |
Valuation ($) | Valuation ($) 25.6 m | Valuation ($) N/A | Valuation ($) 926.7 k | Valuation ($) 39.2 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $7.9m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($69.2m) (FY, 2023) | Net income N/A | Net income (£5.9m) (FY, 2023) | Net income ($62.7m) (FY, 2023) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 177.5m | Total funding raised N/A | Total funding raised $ 33.2m | Total funding raised $ 160m | Total funding raised $ 21.9m |
Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases.
View companyTC Biopharm (Holdings) is a clinical-stage cell therapy company developing immunotherapy products.
View companyNextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.
View companyImmunicom is a company that develops and commercializes a non-drug-based cancer therapy in order to reduce treatment side effects and enhance its response rates.
View company